Clarimedix, Inc - Product Pipeline Analysis - New Market Report Now Available
Clarimedix, Inc. (Clarimedix) is a clinical-stage therapeutic device company. It develops therapeutic products for diseases related with vascular dysfunction. Clarimedix's technology is a nitric oxide donor therapy which exploits recent developments in cellular function enabling to control it with light. Its pipeline of products includes treatments for Raynaud's syndrome, Alzheimer's disease and Cerebral Vasospasm. Through its proprietary 'formulation' of light, the product is capable of triggering targeted, localized and controllable nitric oxide production. Clarimedix is headquartered in Aurora, Colorado, the...
View full press release